Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Glenmark Pharmaceuticals Limited ( (IN:GLENMARK) ).
Glenmark Pharmaceuticals has disclosed that the Goods & Service Tax Department, Mumbai, conducted a search, seizure and inspection operation at its offices under Section 67 of the Maharashtra Goods and Services Tax Act, 2017. The inspection, led by the Assistant Commissioner of State Tax (Investigation – B, Mumbai), ran from January 27 to January 31, 2026, with the company stating it fully cooperated by providing all requested documents and clarifications, and noting that no official document has been issued indicating adverse findings and that the exercise has had no material impact on its financials, operations or other activities.
More about Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited is an India-based pharmaceutical company active in the research, development, manufacturing and marketing of branded and generic formulations as well as specialty products for domestic and international markets. The company operates in the healthcare and life sciences industry, supplying medicines across multiple therapeutic segments and serving both regulated and emerging markets.
Average Trading Volume: 19,070
Technical Sentiment Signal: Strong Buy
Current Market Cap: 569.2B INR
For a thorough assessment of GLENMARK stock, go to TipRanks’ Stock Analysis page.